Geode Capital Management
GRI

Geode Capital Management’s GRI Bio GRI Stock Holding History

Geode Capital Management’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Sell
13,869
-4,569
-25% -$10.1K ﹤0.01% 4357
2026
Q1 		$42.2K Buy
18,438
+17,610
+2,127% +$65.6K ﹤0.01% 4354
2025
Q4 		$5.72K Buy
828
+386
+87% +$16.6K ﹤0.01% 4454
2025
Q3 		$25.5K Buy
+442
New +$20.4K ﹤0.01% 4396
2025
Q1 		– Sell
-160
Closed -$63.1K – 4492
2024
Q4 		$63.1K Buy
160
+135
+540% +$46.2K ﹤0.01% 4200
2024
Q3 		$4.28K Buy
+25
New +$10.1K ﹤0.01% 4518
2024
Q1 		– Hold
0
– -$5.66K – 4620
2023
Q4 		– Hold
0
– – – 4630
2023
Q3 		– Hold
0
– – – 4590
2023
Q2 		– Hold
0
– – – 4452
2023
Q1 		– Hold
0
– – – 4776
2022
Q4 		– Hold
0
– – – 4875
2022
Q3 		– Hold
0
– – – 5008
2022
Q2 		– Hold
0
– – – 4971
2022
Q1 		– Hold
0
– – – 4846
2021
Q4 		– Hold
0
– – – 4713
2021
Q3 		– Hold
0
– – – 4503
2021
Q2 		– Hold
0
– – – 4616

Other funds holding GRI

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Geode Capital Management's GRI Position: Q2 2026 in Review

Geode Capital Management reduced its GRI Bio (GRI) stake by 25% in Q2 2026, selling an estimated $10.1K and leaving 13,869 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4357.

Geode Capital Management first reported a position in GRI in Q3 2024 and has held it in 6 quarters since. The position peaked at $63.1K in Q4 2024. 11 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • Geode Capital Management held 13,869 shares of GRI Bio worth $24.5K as of Q2 2026.
  • Geode Capital Management sold 4,569 GRI Bio shares in Q2 2026, an estimated $10.1K.
  • GRI Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4357 holding.
  • Geode Capital Management first reported a position in GRI Bio in Q3 2024 and has held it in 6 quarters since.
  • Geode Capital Management's GRI Bio position peaked at $63.1K in Q4 2024.
  • 11 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.